Dr. Joensuu Discusses Resistance to Imatinib in GIST

Update on the treatment of GISTПодробнее

Dr. Joensuu Discusses the Progress of GIST TreatmentsПодробнее

Longer Adjuvant Imatinib Therapy Better in High-Risk GISTПодробнее

Resistance to TKI Therapies in GISTПодробнее

Dr. Keedy on Resistance in Patients With GISTПодробнее

Adjuvant Treatment in Gastrointestinal Stromal Tumor (GIST)Подробнее

Dr. Joensuu Summarizes the Imatinib for High-Risk GIST TrialПодробнее

Therapeutic strategy in GIST tumorsПодробнее

GIST: Assessing Response to Imatinib TherapyПодробнее

Advances in Therapy for Sarcomas & GISTПодробнее

The Role of Adjuvant Therapy for GISTПодробнее

Dr. Keedy on Regorafenib for the Treatment of GISTПодробнее

Diagnosis of Metastatic GISTПодробнее

Mastering GIST treatment: Imatinib and other targeted therapy for gastrointestinal stromal tumorsПодробнее

Optimizing treatment approaches for the management of GISTПодробнее

Advancements in GIST: Medication, Imaging, and SurgeryПодробнее

Dr. Singh Discusses Immunotherapy Study in GISTПодробнее

Side Effects Associated With Gleevec for GISTПодробнее

Side Effects Associated With Other Treatments for GISTПодробнее